![Elizabeth Gordon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elizabeth Gordon
Consigliere Generale presso Excaliard Pharmaceuticals, Inc.
Profilo
Elizabeth Gordon is currently the Head of Regulatory Affairs & Project Management at Excaliard Pharmaceuticals, Inc. Prior to this, she was the Senior Vice President of Regulatory Affairs at Amplyx Pharmaceuticals, Inc. from 2019 to 2021 and held the position of Senior Director of Regulatory Affairs at Quintiles Transnational Corp.
Dr. Gordon has a doctorate degree from the University of Rhode Island, a graduate degree from the University of Maryland, and an undergraduate degree from the University of New Hampshire.
Posizioni attive di Elizabeth Gordon
Società | Posizione | Inizio |
---|---|---|
Excaliard Pharmaceuticals, Inc.
![]() Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Consigliere Generale | 06/08/2009 |
Precedenti posizioni note di Elizabeth Gordon
Società | Posizione | Fine |
---|---|---|
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/06/2021 |
Quintiles Transnational Corp.
![]() Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Consigliere Generale | - |
Formazione di Elizabeth Gordon
University of Rhode Island | Doctorate Degree |
University of New Hampshire | Undergraduate Degree |
University of Maryland | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Excaliard Pharmaceuticals, Inc.
![]() Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
Quintiles Transnational Corp.
![]() Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Elizabeth Gordon